43 studies found for:    NIAID | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
21 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
22 Not yet recruiting Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID ΔM2-2 Vaccine;   Biological: Placebo Vaccine
23 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine
24 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
25 Recruiting Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
Condition: Shigella Infection
Interventions: Other: Placebo;   Biological: WRSs3;   Biological: WRSs2
26 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
27 Recruiting Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV003;   Biological: rDEN2∆30-7169;   Biological: Placebo
28 Recruiting Staged Phase I/II Hepatitis C Prophylactic Vaccine
Condition: Hepatitis C
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut;   Other: Placebo
29 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Volunteers
Intervention:
30 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
31 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
32 Recruiting Phase I STEBVax in Healthy Adults
Condition: Toxic Shock Syndrome Staphylococcal
Intervention: Biological: STEBVax
33 Not yet recruiting Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX B/E®;   Biological: Placebo vaccine
34 Not yet recruiting Collection of Biological Material From Pregnant Women in a Malarial Region
Condition: Malaria
Intervention:
35 Not yet recruiting Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) and 13-valent Pneumococcal Conjugate Vaccine (PREVNAR 13®)
Condition: Pneumococcal Infection
Intervention: Biological: PNEUMOVAX and PREVNAR
36 Not yet recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
37 Recruiting Causes of Rotavirus Vaccine Failure in Zambian Children
Condition: Diarrhoea
Intervention:
38 Recruiting VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Conditions: Immunity, Mucosal;   Immune System Processes;   Blood Specimen Collection
Intervention:
39 Recruiting Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants
Condition: Tuberculosis
Interventions: Biological: AERAS-404;   Biological: Placebo
40 Recruiting Immune Memory After Papillomavirus Vaccination
Condition: Healthy Volunteers
Intervention: Drug: quadrivalent HPV vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-43) Show next page of results
Indicates status has not been verified in more than two years